Paper II
2022 May (Supplementary) (2010 Scheme)
Question
Glibenclamide/Glipizide in elderly patients
Q140.3 marksShort Answers
Answer
Glipizide is the appropriate choice — a shorter-acting sulfonylurea with no active metabolites, giving a lower risk of prolonged or severe hypoglycemia in elderly patients. Glibenclamide has a longer duration of action and active metabolites that can accumulate (particularly with age-related decline in renal function), carrying a substantially higher risk of severe, prolonged hypoglycemia in the elderly — making it a poor choice in this age group.
Related Concepts
Other Years Asked
- 1Define plasma half-life and give two examples of drugs with very short half life. Define therapeutic index and give two examples each for drugs with high and low therapeutic index". (4+4)4. Classify drugs used to treat Parkinsonism with one example from each group2022 February (2019 Scheme)Short Essay · 10 marks
- 2Discuss the factors modifying drug action. Describe the clinical importance of plasma protein binding of drugs. (4+4)2024 June (Supplementary) (2019 Scheme)Short Essay · 8 marks
- 3Briefly describe kinetics of elimination. Add a note on factors modifying drug action. (4+4)2023 January (Supplementary) (2019 Scheme)Short Essay · 8 marks
- 4Briefly describe drug biotransformation. Describe microsomal enzyme induction. (4+4)2023 July (Supplementary) (2019 Scheme)Short Essay · 8 marks
- 5Define bioavailability. What are the factors that affect bioavailability of drugs (1+5)2024 December (Supplementary) (2019 Scheme)Short Essay · 6 marks
- 6Briefly describe kinetics of elimination.2025 March (Supplementary (SAY)) (2019 Scheme)Short Answer · 4 marks
- 7Briefly describe enzyme induction and enzyme inhibition with suitable examples.2024 March (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 8Contra indications and drug interactions of oral contraceptive pills.2025 March (Supplementary (SAY)) (2019 Scheme)Short Answer · 4 marks
- 9Plasma half life2022 October (Supplementary) (2010 Scheme)Short Note · 3 marks
- 10First pass metabolism.2016 October (Supplementary) (2010 Scheme)Short Note · 3 marks
- 11Desferrioxamine2018 July (Supplementary) (2010 Scheme)Short Note · 3 marks
- 12Microsomal enzyme induction2013 September (Supplementary) (2010 Scheme)Short Note · 3 marks
- 13Plasma half life2018 February (2010 Scheme)Short Note · 3 marks
- 14Define half life of a drug and give its clinical significance2024 August (Supplementary) (2010 Scheme)Short Note · 3 marks
- 15Adverse effects of oral contraceptives2015 February (2010 Scheme)Short Note · 3 marks
- 16Plasma half-life2014 March (2010 Scheme)Short Note · 3 marks
- 17Bioavailability.2016 February (2010 Scheme)Short Note · 3 marks
- 18Apparent volume of distribution2019 February (2010 Scheme)Short Note · 3 marks
- 19First pass metabolism2019 July (Supplementary) (2010 Scheme)Short Note · 3 marks
- 20Kinetics of elimination2013 April (2010 Scheme)Short Note · 3 marks
- 21Pharmacogenetics2021 February (Supplementary) (2010 Scheme)Short Note · 3 marks
- 22Plasma half life2021 December (Supplementary) (2010 Scheme)Short Note · 3 marks
- 23Insulin Glargine2019 February (2010 Scheme)Short Note · 3 marks
- 24Dipivefrine2017 February (2010 Scheme)Short Answer · 1 mark
- 25Mention two differences between tetracycline and doxycycline2013 April (2010 Scheme)Short Answer · 1 mark
- 26Low dose ritonavir2018 July (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 27Select the CORRECT statement regarding protein binding of drugs: 1. Protein bound drug is not available for action. 2. Highly plasma protein bound drugs tend to have high volume of distribution. 3. Highly protein bound drugs are generally long acting. 4. Basic drugs are generally bound to albumin.2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 28Assertion (A): Azathioprine dose is decreased with Allopurinol. Reason (R): Azathioprine and allopurinol cause bone marrow suppression.2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (A/R) · 1 mark
- 29Enzyme inducers2014 March (2010 Scheme)Short Answer · 1 mark
- 30Imipenem with cilastatin2021 December (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 31The following insulin is preferred to be given intravenously in diabetic ketoacidosis:2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 32Ritonavir in low doses in various Anti retroviral regimes2024 August (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 33The Dopamine agonists used to treat Parkinson’s disease are:2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (Multi) · 1 mark
- 34Plasma half life and its clinical relevance.2016 February (2010 Scheme)Short Answer · 1 mark
- 35The antihistaminic drug banned due to the deaths caused by Torsades de pointes is2025 March (Supplementary (SAY)) (2019 Scheme)MCQ · 1 mark
- 36Which of the following diuretics are used to treat hyperaldosteronism2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (Multi) · 1 mark
- 37Oral anticoagulants2018 July (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 38The following statements about iron kinetics is FALSE:2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 39Atracurium2018 February (2010 Scheme)Short Answer · 1 mark
- 40Causing peripheral neuritis2018 July (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 41Comment on the drug interaction produced by sulfonylureas and salicylates.2013 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 42Pro drugs2017 August (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 43Chemical antagonism with one example.2014 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 44The factor which does not govern the volume of distribution of a drug is2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 45Hofmann elimination2013 April (2010 Scheme)Short Answer · 1 mark
- 46The WRONGLY paired drug and its influence on thyroid function is:2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 47Imipenem and cilastatin2021 February (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 48What is a pro drug and mention two examples2013 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 49The drug safe in pregnancy2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (Multi) · 1 mark
- 50Microsomal enzyme inducers2019 July (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 51Anti-fungal azole derivative2021 December (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 52Atypical neuroleptics2021 December (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 53Prodrugs2022 October (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 54Prodrugs.2025 March (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 55 Liposomal Amphotericin B in Visceral leishmaniasis. Name the following (Two examples for each) (5x1=5)2024 March (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 56HMG-CoA reductase inhibitor2019 February (2010 Scheme)Short Answer · 0.3 marks
- 57Drugs having high first pass metabolism2024 March (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 58Microsomal enzyme inhibitors2023 January (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 59Prodrugs.2023 July (Supplementary) (2019 Scheme)Short Answer · 0.2 marks

